Abstract A30: Novel non-COX inhibitory sulindac derivative with PDE10 inhibitory activity reduces incidence and multiplicity of colorectal adenomas in the APC+/min-FCCC mouse model

Kevin J. Lee(University of Alabama at Birmingham), Wen‐Chi Chang(National Cheng Kung University), Adam B. Keeton(Washburn University), Ashley S. Lindsey(USA Mitchell Cancer Institute), Joel Andrews(USA Mitchell Cancer Institute), Gary A. Piazza(Auburn University), Xi Chen(Tongji University), Verónica Ramírez‐Alcántara(USA Mitchell Cancer Institute), Jacob Valiyaveettil(USA Mitchell Cancer Institute), Margie L. Clapper
Cancer Research
January 31, 2017
Cited by 1


Related Papers